Skip to main content
OpenTrials
Completed

NCT Number: NCT01440075

Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease

Kawasaki disease (KD) is an acute systemic vasculitic syndrome with coronary tropism.

It has been reported worldwide, but it is ten times more common in Asian population. The annual incidence in children under 5 years in Europe is estimated at 8 to 100000. It is the second vasculitis of the child by its frequency after rheumatoid purpura. It occurs in 80% of cases between 1 and 5 years, with a maximal incidence around the age of 12 months.

It may results in acquired heart disease in children in developed countries, and may be the cause of premature coronary artery disease in adulthood.

A polymorphism was recently associated with the occurrence of disease in a Japanese and U.S population. (C allele of SNP itpkc_3, with a risk multiplied by 2). However, data are conflicting on this issue and the prevalence of this allel is unknown in North America and Europe populations.

The clinical picture of KD associate a persistent fever and an antipyretics resistance with mucocutaneous signs and bulky cervical lymphadenopathy usually unilateral. Diagnosis is confirmed by the presence of five clinical signs (major criteria). The presence of inconsistent coronary lesions in cardiac ultrasound can confirm the diagnosis.

KD can resolve spontaneously with no treatment. The severity of the disease is primarily related to complications of coronary aneurysms in acute or chronic stages.

Several arguments support the fact that adult patients have diffuse vascular lesions different from aneurysmal lesions initially described in childhood.

Despite abundance of publications on KD, there is no prospective or retrospective study which explored anomalies resulting from KD in adult subjects.

Therefore, this project will describe the patient's vascular evolution, the prevalence of atherosclerotic lesions and to determine the biological and functional abnormalities, markers of accelerated atherosclerosis.

Hypothesis : A history of Kawasaki disease represents a cardiovascular risk factor in adulthood.

The main objective is to evaluate the prevalence of atherosclerotic lesions, their extent and their severity in adults with a history of KD in childhood compared to a control population.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hopital cardiologique Louis Pradel

Bron, 69677, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of KD before the age of 18, with or without macroscopic coronary lesions in the childhood phase. (KD group only)
  • 18 years old or older at the time of the study.
  • Agree on participating to all explorations of the study.
  • Accept genotyping.
  • Absence of cardiovascular risk factors

Exclusion criteria

  • Atypical KD (KD group only)
  • Documented or suspected coronary ischemia,
  • Refusal to participate to the study or sign the consent
  • Contra-indication to the injection of iodinated contrast agents (allergy, renal failure)
  • Hypersensitivity to dobutamine,
  • No effective contraception method for females with child bearing potential,
  • Breastfeeding, or pregnant females,
  • Treatment modifying endothelial reactivity
  • History of severe intolerance to iodinated contrast agents,
  • Subjects who can't hold their breath for at least 20 seconds,
  • Irregular or absence of sinus rhythm, especially atrial or ventricular arrhythmia
  • Unability to give information to the subject,
  • No coverage from a Social Security system
  • Deprivation of civil rights

Treatment and study plan

Cardiac evaluation

Other

complete cardiac evaluation with :

Electrocardiogram Echodoppler Echodoppler with dobutamine stress Carotid Echodoppler Coronary scan Positron emission tomography with adenosine stress Blood test (search for early atherosclerosis marker Genotyping

Primary outcomes

  1. Prevalence of carotid and coronary atherosclerotic plaques at vascular Doppler ultrasound and coronary scan in the KD population versus control population

    Time frame: 1 day

Secondary outcomes

  1. Early markers of atherosclerosis

    Time frame: 1 day

    Secondary Outcomes consist of early markers of atherosclerosis:

    • Carotid intima-media thickness
    • Endothelial dysfunction of coronary arteries,
    • Myocardial blood flow at rest and under pharmacological stress (adenosine)
    • Myocardial systolic function overall and segmental at rest and under pharmacological stress (dobutamine)
    • Early biological markers of atherosclerosis.

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Acronym: Kawasaki

Important dates

Study start
2011
Primary completion
2015
Study completion
2015
First posted
Sep 26, 2011
Registry last updated
Aug 22, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.